ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo
Christian Moser(University Hospital Regensburg), Oliver Stoeltzing(The University of Texas MD Anderson Cancer Center)
Cited by 70
Related Papers
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
|American Journal Of Pathology|2003|175
Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model
|International Journal of Cancer|2007|167